Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York.
| Revenue (Most Recent Fiscal Year) | $1.13B |
| Net Income (Most Recent Fiscal Year) | $209.34M |
| PE Ratio (Current Year Earnings Estimate) | 18.86 |
| PE Ratio (Trailing 12 Months) | 20.07 |
| PEG Ratio (Long Term Growth Estimate) | 2.69 |
| Price to Sales Ratio (Trailing 12 Months) | 3.76 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.34 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 17.05 |
| Pre-Tax Margin (Trailing 12 Months) | 24.82% |
| Net Margin (Trailing 12 Months) | 19.13% |
| Return on Equity (Trailing 12 Months) | 12.36% |
| Return on Assets (Trailing 12 Months) | 6.39% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.68 |
| Quick Ratio (Most Recent Fiscal Quarter) | 2.20 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.56 |
| Inventory Turnover (Trailing 12 Months) | 3.35 |
| Book Value per Share (Most Recent Fiscal Quarter) | $36.10 |
| Earnings per Share (Most Recent Fiscal Quarter) | $1.22 |
| Earnings per Share (Most Recent Fiscal Year) | $4.21 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.27 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Common Shares Outstanding | 49.54M |
| Free Float | 48.74M |
| Market Capitalization | $4.20B |
| Average Volume (Last 20 Days) | 0.32M |
| Beta (Past 60 Months) | 0.50 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.60% |
| Percentage Held By Institutions (Latest 13F Reports) | 99.95% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |